drugset / Trial / NCT00004368

Phase I Study of Colchicine Therapy in Childhood Hepatic Cirrhosis

NCT00004368

Treatment

Summary

OBJECTIVES: I. Investigate the efficacy and safety of colchicine therapy in improving hepatic function and reducing hepatic fibrosis (scarring) in children with hepatic cirrhosis.

Timeline

Start
1990-05
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Colchicine Small molecule Oral

Indications